Preventive effect of L-carnosine on changes in the thermal nociceptive threshold in streptozotocin-induced diabetic mice.

[1]  M. Ohsawa,et al.  Preventive effect of acetyl-L-carnitine on the thermal hypoalgesia in streptozotocin-induced diabetic mice. , 2008, European journal of pharmacology.

[2]  M. Pauza,et al.  Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity , 2008, Molecular pain.

[3]  A. Majid,et al.  Carnosine Is Neuroprotective Against Permanent Focal Cerebral Ischemia in Mice , 2007, Stroke.

[4]  M. Stevens,et al.  Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[5]  Fei Li,et al.  The Leptin-Deficient (ob/ob) Mouse , 2006, Diabetes.

[6]  A. Hipkiss.  Would Carnosine or a Carnivorous Diet Help Suppress Aging and Associated Pathologies? , 2006, Annals of the New York Academy of Sciences.

[7]  T. Ohgami,et al.  Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. , 2006, Diabetes.

[8]  E. Feldman,et al.  Oxidative stress in the pathogenesis of diabetic neuropathy. , 2004, Endocrine reviews.

[9]  N. Calcutt,et al.  Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor , 2004, Diabetologia.

[10]  S. Chung,et al.  Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress , 2003, Molecular and Cellular Neuroscience.

[11]  A. Boulton,et al.  Neurovascular disease, antioxidants and glycation in diabetes , 2002, Diabetes/metabolism research and reviews.

[12]  D. Greene,et al.  An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  R. Wada,et al.  Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. , 2001, Brain : a journal of neurology.

[14]  C. Cheng,et al.  Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. , 2001, Brain : a journal of neurology.

[15]  J. Dunlap,et al.  Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. , 2001, Diabetes.

[16]  M. Cotter,et al.  Effect of α-lipoic acid on vascular responses and nociception in diabetic rats , 2001 .

[17]  A. Vinik,et al.  Diabetic neuropathies , 2000, Diabetologia.

[18]  R. Holliday,et al.  A role for carnosine in cellular maintenance. , 2000, Biochemistry. Biokhimiia.

[19]  T. Larson,et al.  Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. , 2000, Diabetes care.

[20]  A. Clark,et al.  Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. , 1999, Brain : a journal of neurology.

[21]  N. Hotta,et al.  A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. , 1999, Diabetes.

[22]  T. Hohman,et al.  Protein kinase C effects on nerve function, perfusion, Na+,K+-ATPase activity and glutathione content in diabetic rats , 1999, Diabetologia.

[23]  M. Ohsawa,et al.  Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. , 1999, European journal of pharmacology.

[24]  N. Hotta,et al.  Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. , 1998, The Journal of pharmacology and experimental therapeutics.

[25]  D. Miller,et al.  The dipeptide carnosine constricts rabbit saphenous vein as a zinc complex apparently via a serotonergic receptor. , 1996, The Journal of physiology.

[26]  Y. Naito,et al.  The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-aminopropionyl)-L-histidinato zinc. , 1991, Biochimica et biophysica acta.

[27]  Paul J Thornalley.  Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. , 2002, International review of neurobiology.

[28]  N. Calcutt.  Potential mechanisms of neuropathic pain in diabetes. , 2002, International review of neurobiology.

[29]  M. Cotter,et al.  Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. , 2001, Free radical biology & medicine.

[30]  H. Abe,et al.  Effects of carnosine and related compounds on the stability and morphology of erythrocytes from alcoholics. , 2000, Alcohol and alcoholism.

[31]  T. Omata,et al.  Effect of Z-103 on compound 48/80-induced gastric lesions in rats. , 1989, Scandinavian journal of gastroenterology. Supplement.